Patterns of Recurrence and Outcomes Following Induction Bacillus Calmette-Guerin for High Risk Ta, T1 Bladder Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patterns of Recurrence and Outcomes Following Induction Bacillus Calmette-Guerin for High Risk Ta, T1 Bladder Cancer

Published:2007-05 Issue:5 Volume:177 Page:1727-1731
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Lerner Seth P.¹,Tangen Catherine M.²,Sucharew Heidi²,Wood David³,Crawford E. David⁴

Affiliation:

1. Scott Department of Urology, Baylor College of Medicine, Houston, Texas

2. Statistical Center, Southwest Oncology Group, Seattle, Washington

3. Urology Department, University of Michigan, Ann Arbor, Michigan

4. Urology Department, University of Colorado, Boulder, Colorado

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference14 articles.

1. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study;Lamm;J Urol,2000

2. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials;Sylvester;J Urol,2002

3. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder;Dinney;J Urol,1998

4. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy;Dutta;J Urol,2001

5. A phase IIB trial of BCG combined with interferon alpha for bladder cancer;Esuvaranathan;J Urol,2000

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacillus Calmette–Guérin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections;APMIS;2020-01-28

2. CIS of the Bladder: Significance and Implications for Therapy;Bladder Cancer;2019-11-22

3. Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations;European Urology;2018-11

4. Re: Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes;Journal of Urology;2017-04

5. The evolving genomic landscape of urothelial carcinoma;Nature Reviews Urology;2017-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3